Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vimian Group AB ( (SE:VIMIAN) ) has issued an update.
Vimian Group AB announced an increase in its number of shares and votes due to the issuance of D shares, E1 2025 shares, E2 2025 shares, and E3 2025 shares as part of its incentive program LTIP 2025/2028. This change reflects a strategic move to enhance its market positioning and operational capabilities, potentially impacting stakeholders by increasing the company’s voting power and share distribution.
The most recent analyst rating on (SE:VIMIAN) stock is a Hold with a SEK39.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
More about Vimian Group AB
Vimian is a global animal health company operating in four key areas: Specialty Pharma, MedTech, Veterinary Services, and Diagnostics. Based in Stockholm, Sweden, the company aims to provide innovative animal health solutions to veterinary professionals and pet owners worldwide, reaching over 17,000 veterinary clinics and laboratories across more than 80 markets.
Average Trading Volume: 515,423
Technical Sentiment Signal: Sell
Current Market Cap: SEK16.57B
Learn more about VIMIAN stock on TipRanks’ Stock Analysis page.